Lisa G. Wolf

Lisa G. Wolf, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Resonant Inc and Valion Bio, Inc. The record holds 12 filings, for trades running from 14 May 2021 to 18 September 2026.

Sales make up the whole of the open-market record (4 sales, €35k). The rest of the record consists of 3 share grants and 4 option exercises.

Most recently, on 24 September 2026, the filings show a share grant worth €4 in Valion Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.